Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients

被引：5
|
作者：
Chalayer, Emilie [1 ,2 ]
Tardy-Poncet, Brigitte [3 ]
Montmartin, Aurelie [3 ]
Boussoualim, Karima [1 ]
Genthon, Alexis [1 ]
Tardy, Bernard [2 ]
机构：
[1] Inst Cancerol Lucien Neuwirth, Dept Hematol, St Priest En Jarez, France
[2] CHU St Etienne, Ctr Invest Clin, CIC 1408, Inserm, St Etienne, France
[3] Univ J Monnet, Equipe DVH, INSERM U1059, St Etienne, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 186卷 / 02期
关键词：
venous thrombosis; neoplasm; low-molecular-weight heparin; multiple myeloma; lymphoma; coagulation tests; ASPIRIN;
D O I：
10.1111/bjh.15815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：337 / 339
页数：3
相关论文
共 50 条
  • [41] The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma
    E Terpos
    M-A Dimopoulos
    O Sezer
    Leukemia, 2007, 21 : 1875 - 1884
  • [42] Individual quality of life in patients with multiple myeloma
    Duerner, Julia
    Reinecker, Hans
    Csef, Herbert
    SPRINGERPLUS, 2013, 2 : 1 - 8
  • [43] Mechanisms of resistance to daratumumab in patients with multiple myeloma
    Iversen, Katrine Fladeland
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 (04) : 401 - 408
  • [44] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [45] The effect of immunomodulatory drugs on bone metabolism of patients with multiple myeloma
    Liu, Yang
    Li, Bo
    Chen, Xiaomin
    Xiong, Hao
    Huang, Chunlan
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (1-3) : 47 - 54
  • [46] Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
    de Camargo Cury, Priscilla Cury
    Higashi, Fabiana
    Silva Zacchi, Flavia Fernandes
    Palhares, Renata Bacic
    Quero, Adriana Alvares
    Miranda Silva Dias, Ana Luiza
    Cruso, Edvan de Queiroz
    de Moraes Hungria, Vania Tietsche
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (02) : 159 - 163
  • [47] 'X' marks the spot! Utilising factor Xa inhibitors to optimise thromboprophylaxis in multiple myeloma
    Costa, Thomaz Alexandre
    Felix, Nicole
    Richter, Joshua
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (02) : 416 - 417
  • [48] Epidemiology and Risks of Infections in Patients With Multiple Myeloma Managed With New Generation Therapies
    Lim, Chhay
    Sinha, Priyadarshini
    Harrison, Simon J.
    Quach, Hang
    Slavin, Monica A.
    Teh, Benjamin W.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (07) : 444 - +
  • [49] Prognostic Effect of Comorbidity Indices in Elderly Patients With Multiple Myeloma
    Bila, Jelena
    Jelicic, Jelena
    Djurasinovic, Vladislava
    Vukovic, Vojin
    Sretenovic, Aleksandra
    Andjelic, Bosko
    Antic, Darko
    Todorovic, Milena
    Mihaljevic, Biljana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (07) : 416 - 419
  • [50] Effect of different therapeutic regimens on the elderly patients with multiple myeloma
    Ge, Chen
    Cao, Peng
    Xu, Xiang-yang
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (10): : 4421 - 4424
12345